Morris Rosenberg

Morris Rosenberg is an experienced consultant specializing in biologics product development, project management, biosimilars, and antibody drug conjugates since October 2012 at Morris Rosenberg Consulting. Previously, Morris served as Chief Technical Officer at Immunomedics from January 2018 to May 2020, overseeing process sciences, manufacturing, quality, and supply chain management for the launch of Trodelvy in the United States. Prior to that, Morris was the Executive Vice President of Process Sciences at Seattle Genetics from July 2001 to July 2012, contributing to the company's growth from a startup to a commercial biopharmaceutical entity with an oncology product on the market. Earlier roles included leading mammalian cell culture development at Eli Lilly from 1998 to 2001 and serving as Group Leader for Cell Culture at Biogen from 1990 to 1998. Morris earned a Doctor of Science degree in Chemical Engineering from Washington University in St. Louis from 1983 to 1987.